Revenue + Forward P/E
Core Scientific, Inc. (CORZ) quarterly revenue and forward P/EForward P/E: 464.6x
RevenueRevenue (est)Forward P/E
Valuation
Market cap
$6.71B
Enterprise value
$8.56B
P/E ratio (TTM)
-24.56x
P/S ratio (TTM)
21.17x
P/B ratio
-5.84x
EV/Sales
24.13x
EV/EBITDA
-37.38x
Dividend yield
0.00%
Income statement (TTM)
Revenue (TTM)
$319.02M
Gross profit (TTM)
$37.90M
Operating income (TTM)
$-224.55M
EBITDA (TTM)
$-207.85M
Net income (TTM)
$-288.62M
Free cash flow (TTM)
$-450.75M
Margins & returns
Gross margin
16.75%
Operating margin
-28.89%
Profit margin
-342.93%
Return on equity
109.08%
Return on assets
-39.63%
Per-share metrics
EPS (TTM)
-$3.77
Dividend yield
0.00%
Beta
5.50
Capital structure
Cash & equivalents
$311.38M
Total debt
$1.06B
Net debt
$748.95M
Shares outstanding
321.34M
Financial health
Current ratio
1.15
Debt / equity
-1.10
Debt / assets
0.45
Interest coverage
-
| Company | Market cap | P/E | P/S | EV/EBITDA | Div yield |
|---|---|---|---|---|---|
| $5.43T | 31.53x | 19.76x | 25.96x | 0.14% | |
| $4.44T | 40.17x | 10.83x | 30.81x | 0.32% | |
| $3.66T | 22.65x | 8.91x | 14.57x | 0.93% | |
| $1.98T | 61.70x | 24.08x | 44.31x | 0.67% | |
| $1.94T | 27.24x | 13.72x | 18.04x | 0.94% | |
| $1.18T | 7.81x | 3.13x | 5.98x | 0.73% | |
| $6.71B | -24.56x | 21.17x | -37.38x | - |